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Abstract 
Vulvovaginal candidiasis (VVC) is a mucosal infection caused by Candida 
species and represents one of the most common clinical problems in women of 
reproductive age (68,71).  Annually in the United States there are approximately 13 million 
cases of VVC, resulting in 10 million gynecologic office visits per year (38).  It is 
estimated that 75% of women will experience at least one episode in their lifetime, with a 
projected 50% of all women experiencing multiple episodes (23).  Candida albicans is a 
dimorphic commensal organism of the urogenital and gastrointestinal tracts and has been 
identified as the main pathogenic agent in VVC, accounting for approximately 85-90% of 
patients with positive cultures (52).   
 Despite extensive research, the invasive mechanism of vaginal yeast infections is 
not well understood.  Traditionally it has been assumed that changes in the host vaginal 
environment promote the dimorphic transition from blastospore to hyphae, resulting in a 
shift from asymptomatic colonization to symptomatic vaginitis (28).  In contrast to the 
normal, systemic immune response, which confers an aseptic environment for tissue and 
organs, immune responses at the mucosal level are designed to prevent tissue invasion 
and local disease while maintaining an indigenous flora that could be both beneficial and 
pathogenic (28). 
 Since fungi are eukaryotic, the vital cellular mechanisms that are usually targeted 
by modern pharmacologic agents, such as DNA replication and protein translation, are 
either conserved or have a strong homology to their human orthologs.  Obtaining a better 
understanding of natural fungal suppression mechanisms and molecules at the mucosal 
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level may pave the way for the development of more efficacious drugs or preventative 
regiments. 
The mechanism by which the human immune system is able to resist fungal 
invasion at the vaginal mucosa is unknown.  Our research was aimed at finding any host 
factors that might play a role in the suppression of or prevention of a fungal infection at 
the vaginal mucosa.  In order to screen candidate molecules that might be important in 
this type of vaginal defense, we chose a pathogenic C. albicans strain, SC5314, to test 
fungal cell viability upon introduction of the candidate molecules.  
We have identified a host factor that exhibits strong fungicidal activity when 
organically extracted from both human and bovine serum albumins.  Characterization of 
this factor through organic extractions and acetone separations reveal that this molecule is 
a non-polar lipid.  Serum samples that have been thoroughly stripped of fatty acids and 
other lipophilic molecules show no apparent fungicidal activity in cell viability assays. 
Since the factor is extractable from both human and bovine serum albumins, it may be 
conserved among mammals. Identification and characterization of this molecule may 
play a pivotal role in understanding host-Candida interactions at the mucosal membrane 
interface.  Due to its human origin, the use of this factor as an antifungal would be 
extremely advantageous in regards to FDA (Food and Drug Administration) guidelines 
and ADMET (Adsorption, Distribution, Metabolism, Excretion, Toxicology) properties. 
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1 Introduction 
1.1 Objectives 
 Since Candida albicans is routinely found in the vaginal flora as a benign 
commensal, I hypothesize that there is a host factor present in the cervical vaginal fluid 
that inhibits C. albicans from initiating an infection.  The primary objective of this 
masters’ thesis is to investigate the possibility that there’s a host factor responsible for 
preventing C. albicans from starting an infection.  Since serum albumins are utilized as 
molecular transports and are present in high quantities in the vaginal fluid, I hypothesize 
that a previously unidentified inhibitory molecule may be associated with them.  In order 
to separate these molecules from the albumins, organic extractions and separations were 
performed.  From these extracts I isolated a lipophilic component that exhibited strong 
fungicidal activity against a pathogenic Candida albicans strain, SC5314.  All extracts 
that exhibited activity were further characterized through LD50 (Lethal Dose 50%) 
experiments and lipid separations. 
 The eventual identification of the active biomolecule(s) and the elucidation of its 
fungicidal mechanism may help reveal how the human immune system prevents C. 
albicans from establishing an infection of the urogenital tract.  The identified molecule 
could also lead to the development of a new class of antifungals or a novel prophylactic 
therapy. 
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1.2 Background 
1.2.1 Pathogenesis and Virulence of Candida albicans  
Candida albicans is the most frequently isolated invasive fungal pathogen in 
humans, with the majority of infections being localized to the urogenital or orapharangeal 
tracts of the patient (Fidel, 1996).  In addition to localized infections, C. albicans is also able 
to establish a systemic infection in its host.  Once the organism crosses into the 
bloodstream of the patient it is readily able to invade and flourish in major organs such as 
the liver, kidney, heart, and brain.  Infection of these major organs can very easily cause a 
life-threatening infection.  Systemic fungal infections are most common in patients with 
compromised immune systems, such as AIDS patients or those that are currently on 
immuno-suppression therapies.  
C. albicans is a dimorphic fungus that primarily exists and propagates via its 
blastospore phenotype (also called blastoconidia).  Blastospores are characterized by their 
oval-shapes, mono-nucleated cells and propagation through cellular budding (Braun, 1997).  
Upon perception of environmental signals, C. albicans is able to transform into one of 
two filamentous forms: psuedohyphae and hyphae (refer to Figure 1).  Elongated, 
ellipsoidal cells that are attached to one another are referred to as psuedohyphae, while 
cells that are considered to be true hyphae are characterized by a cylindrical cellular 
morphology and are separated by perpendicular septal walls.  These hyphal forms are 
comprised of conjoined cells that are divided by septal walls and are not syncytial in 
composition.  Both the psuedohyphal and hyphal morphologies are routinely referred to 
as filamentous. 
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Throughout the last couple of decades, the filamentous form was commonly 
associated with pathogenicity, but recent genetic and animal studies have shown that both 
forms are needed for C. albicans virulence (Braun, 1997; Gow; Hogan).  The hypothesis that the 
free transition between the organism’s two phenotypes (phenotypic switching) is 
necessary for C. albicans’ virulence is partly based upon the following research findings: 
1. Histological evidence from tissues infected with C. albicans, reveals the 
presence of filaments invading deep into the infected tissues (Gow; Hogan). 
2. C. albicans mutants that were filamentation-deficient exhibited a reduced 
capacity to infect mouse models.  The infected mice also showed a 
reduction in candidiasis-related mortality (Hogan; Lo; Mitchell; Saville). 
3. C. albicans mutants that are deficient in Tup1, a repressor of 
filamentation, were locked in the filamentous form but exhibited no 
virulence in mouse models (Braun 1997; Braun 2000).  
 
C. albicans has evolved into a commensal organism as well as an opportunistic 
pathogen, implying that it is routinely present in what is considered to be a healthy 
mucosal microflora while retaining the ability to establish an infection in its host if 
circumstances allow it to do so.  The ability of a pathogenic microorganism to detect and 
respond to environmental cues that signal an invasion opportunity is a potent survival 
mechanism.  C. albicans is able to control its filamentation via its ability to respond to a 
variety of environmental signals, some of which are listed below (Refer to table 1). 
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Figure 1: Candida albicans dimorphism. (A) Blastospores are unicellular forms of the fungus that divide 
by budding. (B) In the presence of some environmental factors, cylindrical growth of a germ tube will 
begin. (C) Germ tubes extend and septa are laid down behind the extending tip to form a hypha.  The main 
factors that favor filamentation (yeast  hypha) are: temperature 37°C, pH 7.0, an inoculum of 1 X 106 
blastospores/ml, and the presence of different compounds, such as N-acetylglucosamine, proline or serum. 
 (Adapted from Molero) 
 
Inhibition Stimulation 
Low growth temperatures High growth temperatures (37C/98.6F) 
Acidic pH (4-6) High CO2/O2 ratio 
Enriched growth media Neutral pH 
Farnesol (quorum sensing molecule) Nitrogen starvation 
Indole acetic acid (plant hormone) Tyrosol (quorum sensing molecule) 
 
Table 1: Environmental and Chemical Signals for the Stimulation or Inhibition of Filamentation.  A variety 
of changes in environmental conditions as well the presence or absence of specific chemicals, are able to 
induce a hyphal change in C. albicans. 
   (Am. Soc. Microbiol. News; Braun 1997; Enjalbert; Ernst; Gow; Odds 1998; Shephard) 
 
 A couple of the environmental conditions that promote hypha formation are 
consistent with the environment presented during an infection opportunity.  The switch to 
its filamentous form allows the pathogen to increase its ability to adhere to and invade the 
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vaginal epithelial cells as well as upregulate its own production of virulence factors 
(Naglik).  Virulence factors expressed by Candida albicans vary depending on the type of 
infection (i.e, mucosal or systemic), the site and stage of infection, and the nature of the 
host response (Naglik).  It has become apparent that an array of virulence factors are 
involved in the infection process, but no single factor accounts for its pathogenicity and 
not all expressed virulence factors may be necessary for a particular stage of infection 
(Naglik; Cutler; Odds 1994). 
  
1.2.2 Host Factors That Affect Candida albicans’ Filamentation 
Response 
 
 The most prominent induction signal observed between the host and C. albicans 
is the serum-induced filamentation response.  When C. albicans is introduced into serum 
or a medium containing serum, typically at 5-10% concentrations, a very strong hyphal 
response is observed (Hornby).  The serum component responsible for the hyphal response 
is currently unknown. 
 Another fascinating interaction between the fungal pathogen and its host involves 
an ingenious macrophage evasion mechanism.  Upon being engulfed by macrophages, 
phagocytized cells undergo a dramatic reprogramming in their transcription (Lorenz).  The 
engulfed cells quickly turn on their oxidative and starvation stress responses that 
ultimately leads to the production of osmoprotectants and hypha formation.  The hyphae 
become too large for the macrophages to contain and subsequent macrophage lysis occurs 
(Figure2). 
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Figure 2:  Once C. albicans is engulfed by murine macrophages, intracellular cascades are activated, 
causing phenotypic switching and the eventual lysis of the host cells. 
(http://biology.uark.edu/dmcnabb.html) 
 
 Estrogen has also been linked to the induction and elongation of hyphae.  
Experiments performed by Cheng et al. show a dose-dependent, hyphal elongation 
response by C. albicans to 17--estradiol (Cheng).  Interestingly, vaginal epithelial cells 
have been shown to possess fungistatic properties. Upon contact between the vaginal 
epithelial cells and Candida albicans via an acid-labile protein bound to its extra-cellular 
membrane (Barrouse, 2005).  In order for the fungistatic activity to occur, the epithelial cell 
does not even need to be viable (Barrouse 2005).  This activity is evident in vitro but does not 
contribute to any appreciable level of protection against Candida colonization (Barrouse, 
2005).   
 With the exception of the slight fungistatic activity possessed by vaginal epithelial 
cells, no physiologic inhibitor of Candida albicans mucosal infections has been reported 
from mammalian sources.  Our current understanding of the vaginal immune defense 
indicates that there are still large gaps in our knowledge concerning the protective 
mechanisms of the vaginal environment.  The discovery of a novel host molecule with 
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fungicidal activity would help elucidate the host-pathogen interactions responsible for 
vaginal defense.  This thesis investigates one such factor. 
 
1.2.3 Establishment and Dissemination of Vaginal Candidiasis 
 Colonization of the epithelial cells is the first step in the establishment of 
vulvovaginal candidiasis.  Adherence to the host epithelial cells is accomplished either 
through the use of adhesins or the involvement of proteases, which do not necessarily 
have to be enzymatically active in order to be involved in a pathogen-host docking event 
(Naglik).  Although hyphal forms are commonly associated with disease and blastospores 
with benign colonization, blastospores have also been isolated from disease sites (Sobel 
1988). 
 In order to cross tissue planes and establish an invasive infection, Candida 
albicans must invade cells that are not normally phagocytic, such as epithelial and 
endothelial cells.  A common histopathologic finding in all types of candidiasis is the 
presence of fungal cells within these tissues (Filler).  The mechanism by which this 
invasion occurs has been the focus of intense investigation for many years (Filler; Pizarro-
Cerda).  Two methods of cellular invasion have been established in vitro; invasion through 
hydrolytic degradation of the targeted cell wall and the induction of normally 
nonphagocytic cells to engulf the pathogen (Park; Stingaro; Ray).  Recent work by Filler et al 
showed that the yeast adhesin Als3 binds to either a N-cadherin or an E-cadherin of the 
host epithelial cell resulting in the fungal cell being phagocytized (Stingaro; Ray; Hobbs).   
Invasion into the primary layer of cells via enzymatic digestion is more characteristic of 
filamentous Candida due to their upregulation of SAPs (secreted aspartyl proteases), 
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while blastospore entry appears to primarily occur through the induction of phagocytosis 
(Stingaro; Ray; Hobbs).  Candida albicans contains a myriad of proteases, of which only the 
aspartyl protease group is secreted (Naglik).  These SAPs exhibit a broad range of pH 
optima and substrate specificities thereby making them potent virulence factors (Koelsch; 
Naglik).  Once the pathogen has entered the primary infection cells, it is the hyphal form 
that is predominantly responsible for tissue penetration and deeper tissue invasion.  Via 
its filamentous forms, C. albicans is able to progress into the host tissue through further 
cell lysis and secondary blastospore budding (refer to figure 1). 
 If the pathogen is able to cross through the vaginal tissue, entry into the 
bloodstream can occur and a disseminated infection can be established.  Once in the host 
bloodstream, C. albicans is readily able to migrate to other tissues and organs and 
establish a widespread systemic infection.  The stages of infection and the resulting 
establishment of systemic infection are summarized below (refer to figure 4).  It should 
be noted that a systemic Candida albicans infection poses a significant health risk with a 
mortality rate of approximately 50% (Hugonnet). 
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Figure 3:  A schematic diagram illustrating the progression of infection as well as the virulence factors that 
are known or are thought to be associated with each stage of infection.  Candida albicans commonly 
colonizes the epithelial surface (stage1) and causes a superficial infection (stage 2).  Under certain 
conditions when the host is compromised, the fungus is able to establish a deep-seated infection (stage 3) 
through deeper penetration of the host tissues.  Occasionally the fungus is able to establish a disseminated 
infection of the host (stage 4), which allows the pathogen to spread to other systemic tissues and organs via 
the host’s circulatory system. 
(Naglik) 
 
1.2.4 Vulvovaginal Candidiasis: Epidemiology 
 Vulvovaginal Candidiasis (VVC) is a mucosal infection of the urogenital tract of 
women and is primarily caused by Candida albicans (Sobel, 1998).  VVC is characterized by 
itching, burning, soreness, abnormal vaginal discharge, dysparunia, and phenotypical 
signs such as vaginal and vulvar erythema and edema (Sobel, 1990).  Some exogenous factors 
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that have been linked to idiopathic VVC include changes or imbalances in reproductive 
hormones, as a result of oral contraception, pregnancy, or hormone replacement therapy 
(HRT), as well as antibiotic usage, and diabetes mellitus (Sobel, 1998).  Most episodes of 
VVC respond well to treatment with currently available antifungals. 
 While acute VVC is largely treatable with current chemotherapeutics, there 
remains a subset of the population (5%-10% of women diagnosed with VVC) that exhibit 
recurrent VVC (RVVC).  RVVC is defined as having three or more episodes per annum 
(Sobel, 1992).  RVVC can be further broken down into two subgroups: primary and 
secondary RVVC.  Primary infections are idiopathic and do not correlate to any known 
predisposing factors identified with acute VVC (Sobel, 1992).  Secondary infections are 
defined as frequent episodes of acute VVC brought on by unavoidable predisposing 
factors such as diabetes mellitus or hormone replacement therapy (Vanden-Bossche).  Women 
who are diagnosed with RVVC usually respond favorably to antifungal therapies with 
very little resistance. It has widely been accepted that women with primary RVVC are 
missing an important protective immune factor.  Following a typical antifungal regimen 
for a symptomatic episode, if the pathogen was not fully eradicated, it could easily 
increase in population and cause recurrent infections through relapse (Sobel, 1992).  A 
summary of the epidemiology of VVC and RVVC is provided in Table 2. 
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Percentage of healthy individuals asymptomatically colonized  5-20% 
Lifetime occurrence of at least one episode of vaginal 
  candidiasis in healthy women 
 
50-75% 
Candida albicans as causative agent 85-90% 
Predisposing factors for infection  
Antibiotics 
High-estrogen contraceptive therapy 
Steroids 
Chronic mucocutaneous candidiasis 
Chemotherapy 
     Lymphoma/hematologic malignancy 
     Transplantation (allogeneic) 
AIDS 
 
+++ 
++ 
+ 
+/- 
 
+/- 
+/- 
+/- 
Prevalence of Primary RVVC in healthy women 5% 
Antifungal resistance rare 
+++, strong role; ++, intermediate role; +, weak role; +/-, little if any role 
 
Table 2:  A brief summary of the epidemiology and factors affecting vaginal C. albicans infection. (+++, 
strong role; ++, intermediate role; +, weak role; +/-, little if any role) 
(Adapted from Fidel, 2007) 
 
1.2.5 Host Defense against Vaginal Candidiasis 
 As a result of the staggering numbers of Candida albicans infections per year, the 
majority of all healthy adults have developed a Candida-specific adaptive immunity. This 
adaptive was immunity is demonstrated by the presence of serum/mucosal antibodies, in 
vitro T-cell responses, and delayed skin test reactivity (Fidel, 2007; Calderone).  What role these 
adaptive immune responses play in the prevention of or protection against Candida 
infections of the urogenital tract is not fully known, but the latest experimental findings 
show that their contributions appear to be nominal (Calderone).  
 Over the past 20 years, there have been innumerable studies pertaining to host-
pathogen interactions and the mechanisms of urogenital infections by Candida albicans.  
Despite the large number of studies undertaken to identify the protective host 
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mechanisms against vaginitis we still do not have a complete understanding of how our 
immune system deals with potentially pathogenic commensals of the urogenital tract. 
 Mucosal candidiasis includes orapharyngeal, esophageal, gastrointestinal, and 
vaginal infections (Fidel, 2007).  Prior to the AIDS epidemic, researchers thought that all 
mucosal membranes were equally susceptible to Candida infection through the same 
mechanism (Fidel, 2007).  A large percentage of AIDS patients suffering from T-cell 
immuno-suppression developed mucosal candidiasis (mainly orapharyngeal in nature), 
and experimental models showed a strong role for T cells against Candida infection (Fidel, 
2007).  Clinical studies and animal models investigating RVVC showed no role for 
systemic or local cell-mediated immunity (CMI) or a shift in a Candida-specific Th1 to a 
Th2 response at the vaginal mucosa  (Fidel,2007; Clift; Romani; Klein; Samaranayake; Sohnle; Fidel, 
(1994),Saavedra; Fidel, 1999).  The lack of a systemic immune response at the urogenital tract 
against Candida is further backed by the observation that although female AIDS patients 
are commonly infected with oral candidiasis, vaginal candidiasis was no more prevalent 
than in the healthy population (Ferrante; Fidel, 1995; Fidel, 1993). 
 Puzzled as to why there was a lack of a T-cell response at the vaginal mucosa 
although a Candida-specific Th1-type immunity was evident in the blood and draining 
lymph nodes in mice, Fidel et al. began to research the mechanism that was preventing 
CMI from protecting against vaginal candidiasis.  Their resulting experiments revealed 
that a strong downregulatory cytokine, TGF-, was constitutively present at the vaginal 
mucosa and its expression and secretion by vaginal epithelial cells was transiently 
increased in response to either an infection or estrogen (Hobbs).  Other cytokines that affect 
Th1/Th2 cells were extremely low during infection (Hobbs).  From this new study, the 
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current paradigm of immunoregulation emerged as an explanation for the apparent lack 
of CMI protection against vaginal infection.   Fidel has proposed that since Candida 
albicans is a vaginal commensal, the evolution of immunoregulation to avoid chronic 
inflammation at the reproductive tissue of the host, would only strengthen their symbiotic 
relationship (Fidel, 2003). 
 Investigations into the possible role of innate immunity at the vaginal mucosa 
showed that there was no detectable correlation between the presence of 
polymorphonuclear neutrophils (PMNs) and natural killer cells (NKs) and a response to 
an infection (Fidel, 2007; Fidel, 1999; Saavedra; Sohnle; Steele 1999a; Parr; Black; Carlsten).  However, during 
these experiments, Fidel et al. discovered that vaginal epithelial cells from mice, humans, 
and macaques have the ability to inhibit C. albicans growth (Fidel, 2007; Steele, 1999a; Steele1999b, 
1999b).  This inhibitory activity was elucidated to be an acid-labile protein bound to the 
vaginal epithelial cell wall that upon contact with Candida albicans causes an unknown 
intracellular event resulting in the inhibition of its growth (Barrouse, 2005; Nomanbhoy).  This 
activity was also evident in oral epithelial cells (Barrouse, 2005; Nomanbhoy).  Since this activity is 
fungistatic and not fungicidal, it may provide evidence of a host mechanism to control 
commensalism.  Clinical studies comparing the role of this fungistatic mechanism in 
healthy and RVVC afflicted women revealed that there was only a minor reduction in 
fungistatic activity in those with RVVC (Nomanbhoy).   Since the reduction of activity was 
minor, researchers believe that there are other undiscovered host factors that are 
responsible for protection against fungal vaginitis Barrouse, 2005 ; (Fidel, 2007).  This research 
project aims to identify and characterize such host factors. 
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1.2.6 Composition of Cervical-Vaginal Fluid 
 The mucosal fluid covering the vaginal epithelium is primarily made up of 
endometrial and oviductal fluids, secretions from cervical vestibular glands, and plasma 
transudate (Wagner).  The molecular components of the fluid include inorganic salts, urea, 
amino acids, proteins, and a number of fatty acids; the fatty acids primarily provided by 
commensal organisms, of which Lactobacillus spp. predominate (Tang).  Recently, the 
proteome of the cervical-vaginal fluid (CVF) of lavages obtained from healthy and 
Candida-colonized vaginas has been elucidated (Tang).  Tang et al. discovered that there 
were surprisingly high levels of normal serum proteins present in the cervical-vaginal 
fluid.  The serum proteins, albumin, immunoglobulin chains, and transferrin were found 
in relative abundance and accounted for 47% of all proteins identified within the fluid 
(Tang).  Another startling discovery was the absence of proteins associated with vaginal 
commensal bacteria.  Out of the 147 proteins identified, only one protein, an 
oligopeptide/dipeptide ABC transporter of Lactobacillus reuteri (Accession #Q1U7T2), 
was identified. 
 A further examination of the protein maps generated by Tang et al. showed a 
clear increase in the amounts of serum proteins in lavages obtained from Candida-
infected patients compared to that of healthy patients (Tang).  Although the levels of serum 
proteins found in the lavages from colonized patients increased, the proportions of other 
non-serum protein components were not significantly altered (Tang).  In comparison to 
fluids from other mucosal membranes, such as the oral and nasal passages, only 16 
proteins are conserved (Hu; Tang).  If these proteins, or factors associated with them, play a 
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role in host-commensal/pathogen regulation it may account for the difference seen in the 
human immune response against Candida albicans between these two mucosal 
environments. 
 
1.2.7 Serum Albumins as Small Molecule Transporters 
 Human serum albumin (HSA) is the most abundant protein in blood plasma and 
serves as a transport and depot protein for numerous endogenous and exogenous 
compounds (45). One of the primary transport roles of HSA is to carry fatty acids, which 
are poorly soluble in an aqueous environment (45). HSA binding to ligand results in an 
increased solubility in plasma, decreased toxicity, and protection against oxidation of the 
bound ligand (Kragh-Hansen, 2002). 
 HSA is a single chain, 66.5 KDa protein synthesized in and secreted from liver 
cells (Peterson).  It is normally a simple, heart-shaped protein lacking prosthetic groups and 
covalently bound carbohydrates and lipids.  X-ray diffraction has shown that the protein 
has three homologous domains (I-III), and that each of these is comprised of two 
subdomains (A and B) (Figure 3) (Barrouse, 2005).  In addition to HSA’s noncovalent binding 
properties, it also retains the ability to covalently bind ligands via its free cysteine residue 
(
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Cys). 
 The ground-breaking work of Sudlow et al. revealed that most small molecules 
bind with high affinity to one of two sites, called Sudlow site I and Sudlow site II (Sudlow).   
Site I is formed as a pocket in subdomain IIA and involves the lone tryptophan of the 
protein (Hu; Sugio; Tang).  Site I’s pocket is recognized as being large and flexible and is 
formed from hydrophobic side chains while its entrance is surrounded by positively 
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charged amino acids (Kragh-Hansen, 1983; Kragh-Hansen, 1985; Tang; Yomasaka).  Dicarboxylic acids and 
bulky hetrocyclic molecules with a negative charge localized in the middle of the 
molecule comprise the usual site I ligands (Tang).   
 
 
Figure 4: HSA structure.  The six subdomains of HSA are colored as follows: subdomain IA, blue; 
subdomain IB, cyan; subdomain IIA, dark green; subdomain IIB, light green; subdomainIIIA, orange; 
subdomain IIIB, red.   
Adapted from Ascenzi et al 
 
 Sudlow site II (also known as the indole-benzodiazepam site) is much smaller, 
narrower, less flexible, and is located in subdomain IIIA (Figure 5) (Ascenzi).  Ligand 
binding affinities can be greatly altered by stereoselectivity or by substitution of ligands 
with a relatively small group (Tang).  This is confirmed by the complete inhibition of 
binding of the serum ligand tryptophan by the simple replacement of a methyl group on 
the -hydrogen (Chuang; McMenamy; Peter; Tang). 
 In addition to these two selective binding sites, albumin also contains multiple 
binding sites of varying affinities for non-esterified fatty acid anions and locations for 
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many saturated fatty acids binding sites (Bhattacharya; Tang). These sites are located within 
subdomains, but there are also others that are formed by adjacent subdomains or via the 
external protein residues.  Binding of anions of medium-chain fatty acids and 
monooleoyl-glycerol occur at Sudlow Site II (Kragh-Hansen, 1988; Tang; Thumser). 
 Researchers currently do not have a lucid understanding of the host immune 
mechanisms of the cervical-vaginal tract.  Investigation into the roles of the adaptive and 
innate immune response of the human body has shown that at the vaginal mucosal level, 
they offer no substantial immunity to C. albicans (Fidel 2000).  The low level of protection 
offered by the combined actions of the innate and adaptive immune responses, as well as 
the fungistatic activity exhibited by vaginal epithelial cells, leads researchers to conclude 
that there might be an undiscovered factor responsible for the majority of the protective 
immunity exhibited by a healthy cervical-vaginal tract (Fidel, 2007). 
 An unknown immune factor responsible for comprising the bulk of vaginal 
immunity, doesn’t necessarily have to be vaginal in origin.  Serum proteins found in the 
cervical-vaginal fluid might be directly or indirectly involved in vaginal protection.  
Transporting an immune factor responsible for vaginal immunity is only one possible role 
that serum proteins may be fulfilling.  Of the identified serum proteins found in cervical-
vaginal fluid, albumin would most likely be the transporter, since it is already well 
established as a transport protein. 
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2 Materials and Methods 
2.1 Candida albicans Culture Conditions 
 The C. albicans wild type strain, SC5314 was used for all fungicidal screening 
assays (Gillum).  SC5314 culture stocks were stored in10% glycerol/YPD (0.5% Yeast 
Extract, 1.0% Peptone, and 2.0% Glucose) at -80C.  Cultures were streaked on YPD 
agar plates and grown overnight at 30C.  Each plate was utilized for 2 weeks, at which 
time a new YPD agar plate was streaked for use as an inoculum source for the 
experiments. 10ml of YPD media was inoculated with a single colony of a plated SC5314 
culture.  The culture was then grown up overnight at 30°C with 280 rpm agitation.  Cells 
were harvested by centrifugation and washed twice with 10ml of sterile dH20.  The 
washed cells were resuspended in 1ml of dH20 and an OD600 was taken.  Cell density was 
calculated from the following equation: 1 OD600 = 2.0 X 10
7
 cells/ml.  The cell 
suspension was then normalized to 1.0 X 10
8
 cells/ml. 
 
2.2 Extraction Protocol/Sample Preparation 
 200 mg of albumin was dissolved into 10 ml of deionized H20.  Three, 40% (v/v) 
extractions with N-butanol (Fischer Scientific A383-1) were performed on the albumin 
solutions as stated below.  4 ml of N-butanol was added to each 10 ml sample and 
allowed to mix by rotation at room temperature for 15 minutes.  After rotation the sample 
was centrifuged for 30 minutes at 4C in a Beckman J6 centrifuge (TY JS5.2 rotor) at 
2000 rpm.  The organic layer was separated and the process repeated for a total of three 
extractions. The pooled organic phase was then frozen in liquid nitrogen and lyophilized 
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overnight.  The lyophilized samples were reconstituted in a minimal volume of N-butanol 
(200l N-butanol per sample volume), transferred to reaction tubes (1.5ml 
microcentrifuge tubes), and were dried on low heat. 
 
2.3 GPP Media Formulation 
 The assay media chosen to carry out the fungicidal screening was a Glucose 
Phosphate Proline (GPP) media that was adapted from Hornby, 2004 (Hornby). The defined 
liquid medium contained the following per liter of distilled water: glucose (or sucrose), 
20 g; KH2PO4, 4 g; Na2HPO4, 3.2 g; MgSO4 • 7 H2O, 0.5 g; biotin, 20 g; thiamine • HCl, 
200 g; pyridoxine • HCl, 200 g; ZnSO4 • 7 H2O, 1 mg; MnCl2 • 4H2O, 1 mg; CuSO4 • 
5H2O, 1 mg; FeCl3, 1mg; 10 mM L-proline or 10 mM L-arginine • HCl (pH 6.0 ±0.2). 
The vitamins were prepared as a 1,000 x stock mixture in 20% aqueous ethanol, and the 
trace elements were prepared as a 5,000 x stock solution (5 mg/ml in 0.1 N hydrochloric 
acid).   The vitamin and trace elements stock solutions were then .22µm filtered.  The 
medium ingredients, except carbon and nitrogen sources, were dissolved in distilled 
water, dispensed into culture flasks, and autoclaved at 121°C for 15 min. The nitrogen 
source, proline, was prepared as 100 mM stock solutions, autoclaved separately, and 
added aseptically to the medium to give a final concentration of 10 mM.  Similarly, 
glucose (or sucrose) was prepared as a 20% stock solution, autoclaved separately, and 
added aseptically to the growth medium to give a final concentration of 2%. 
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2.4 Acetone Separation 
 The processed sample was combined with 1 ml of ice-cold acetone 
(Sigma179124), vortexed vigorously for 3 minutes, and left to incubate at 20C for 1 
hour.  The incubated samples were then centrifuged at 14,000Xg for 10 minutes on a 
benchtop microfuge.  The supernatant was aspirated off and saved.  Both the acetone 
pellet and the acetone supernatant then dried. 
 
2.5 Assay Protocol 
 The processed samples that had been dried in the reaction tubes were brought up 
in 10µl tissue culture tested DMSO (SigmaD2438), combined with 170µl of GPP 
filamentation media, and inoculated with 20µl of the normalized SC5314 cell suspension.  
Reaction tubes were allowed to incubate at 37°C, with rotation for 3 hours.  After 
incubation, serial dilutions were performed, and 15µl of each solution was plated onto 
YPD agar and grown overnight at 30°C.  The following morning CFU counts were 
performed on serial dilutions that yielded manageable colony numbers.  Each assay was 
performed in quintuplicate.  Approximately 50-200 colonies were counted per plate. 
 
3 Results 
3.1 Effects of DMSO on Fungal Viability 
 DMSO was added to the screening media to help improve substrate solubility and 
to bypass any rate limiting step such as transmembrane transport in order to enhance the 
substrate’s intracellular bioavailability.  In order to determine the maximum final 
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concentration of DMSO that could be used in the assay that does not interfere with C. 
albicans cell viability, increasing percentages of DMSO were incubated with SC5314 
cells using the established assay procedure stated in the materials and methods section 
above.  Figure 5 demonstrates that a final concentration of 5.0% DMSO is acceptable to 
use in the screening assay since this is the highest concentration tested at which the 
SC5314 cells remain viable. 
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Figure 5:  Increasing percentages of DMSO was incubated with SC5314 cells in order to ascertain the 
maximum DMSO concentration that did not affect cell viability.  N=5.  Error bars represent Standard Error 
of the Mean (SEM). 
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3.2 Fungicidal Activity Is Present in BSA Extracts  
 Since any albumin-associated fungicidal molecule involved in vaginal immunity 
against Candida albicans may very well be conserved among mammalian species, 
process validation and preliminary studies were performed on bovine serum albumin 
(BSA) as a surrogate for human serum albumin (HSA).  Fungicidal activity was 
represented by a decrease in SC5314 cell viability.  Cell viability was measured as the 
percent of viable cells cultured on YPD agar after the assay as compared to that of the 
control cells.  The control utilized for these experiments was the addition of SC5314 cells 
into an aliquot of pure GPP/5%DMSO media with no extract added.  There was no 
change in SC5314 viability when N-butanol by itself was dried in the reaction tubes and a 
control assay was performed (data not shown).  Therefore any decrease in cell viability 
cannot be attributed to the extract solvent.  For this experiment, increasing aliquots of 
stock extract were dried and their affects on cell viability was assayed.  Figure 6 shows 
that approximately 75 g (40 l) of extract exhibited a complete fungicidal effect against 
the SC5314 strain of Candida albicans.  This effect was also seen at subsequent higher 
concentrations.  
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Figure 6:  The effects on cell viability from increasing aliquots of BSA extracts were performed.  N=5.  
Error bars represent Standard Error of the Mean (SEM). 
 
 
 
3.3 Fungicidal Activity Is Present in HSA Extracts 
 Once process and assay validation was completed utilizing BSA samples, HSA 
samples were analyzed in order to link the fungicidal activity recovered from the serum 
albumin extracts directly to a human system.  Figure 7 shows a dose-dependent 
fungicidal effect caused by the extracts of the human serum albumin.  The same assay 
procedures and controls were used as in Experiment 3.2.   At the highest tested dose, 
200µl (375 g), there remains only 18% cell viability when compared to the control 
samples.  Due to extract batch limitations, higher doses were not analyzed.   
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Figure 7:  The effects on cell viability from increasing aliquots of HSA extracts were performed.  N=5.  
Error bars represent Standard Error of the Mean (SEM). 
 
 
3.4 Activity Comparison of BSA and HSA Extracts 
Dosing studies using bovine and human serum albumins were compared side by 
side to evaluate the difference in specific activity.  Since extractions were performed on 
the same amount of starting material and the lyophilized extract for each sample was 
resuspended in the same volume of N-butanol used to comprise the stock solution, the 
difference in activity can be directly attributed to the difference in sample sources.  
Figure 6 shows that BSA extractions yield approximately a 5 fold higher specific activity 
over the HSA samples.   
It can be concluded that there is a difference in fungicidal activity depending on 
the source of the serum albumin (HSA or BSA).  The reason for the difference in 
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fungicidal effect per µl of sample cannot be ascertained from these experiments; however 
since these extractions and experiments were carried out using the same protocol at the 
same time, a processing variation can be ruled out.  The difference in activity may be due 
to differences in physiologic levels of the fungicidal factor associated with serum 
albumins from species to species, or a difference in the predominant isoform of the factor 
between species.  Batch variation cannot be ruled out as the source of the difference in 
activity, but is considered unlikely since consistent activity was obtained from three 
different BSA extractions over the course of approximately one year (data not shown) 
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Figure 8:  The effects on cell viability from increasing aliquots of BSA and HSA extracts were performed 
and compared.  N=5.  Error bars represent Standard Error of the Mean (SEM). 
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3.5 Fatty Acid Free (FAF) BSA Extracts Exhibit No Fungicidal 
Activity  
 
 Since the agent responsible for the fungicidal activity was extracted from the 
albumin using organic solvents, the molecule(s) containing this activity are most 
probably lipids or other hydrophobic small molecules.  To test this theory, albumin 
samples that were stripped of their fatty acids via charcoal treatment under acidic 
conditions were purchased.  The fatty acid free albumin samples were purchased from the 
same vendor and had undergone the same pre-purification regiment that the untreated 
albumin samples had undergone.  Both extractions started from the same amount of 
starting material and were processed in the same manner as stated previously.  The 
control represents fungal cells that had no serum extract added to the assay media.  
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Figure 9:  The effects on cell viability from increasing aliquots of fatty acid free BSA extracts were 
performed and compared against regular BSA extracts.  N=5.  Error bars represent Standard Error of the 
Mean (SEM). 
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 It is evident from the results in Figure 9, that the BSA samples that been stripped 
of their lipophilic molecules exhibit no fungicidal effect.  From these results we are able 
to conclude that the fungicidal factor associated with the BSA is lipophilic in nature. 
 
3.6 Fatty Acid Free (FAF) HSA Extracts Exhibit No Fungicidal 
Activity 
 
 Based upon the results from experiment 3.5, the same study was performed on the 
fatty acid free human serum albumin samples.  The same processing, extraction, and 
assay procedures were followed as in Experiment 3.5.  Figure 10 shows that there was no 
loss in cell viability as compared to the HSA extracts indicating that by stripping the 
albumins of lipophilic molecules we see a complete loss of the fungicidal activity 
exhibited in the non-stripped samples.  This is further evidence that the factor in question 
is indeed a lipophilic molecule and that the factor responsible for the fungicidal activity 
from the BSA and HSA extracts is the same molecule or closely related to one another. 
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Fatty Acid Free HSA Extracts Contain No Fungicidal Activity
As Compared To HSA Extractions
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Figure 10:  The effects on cell viability from increasing aliquots of fatty acid free HSA extracts were 
performed and compared against regular HSA extracts.  N=5.  Error bars represent Standard Error of the 
Mean (SEM). 
 
 
3.7 The Fungicidal Factors from BSA and HSA Extracts Are 
Non-polar Lipophilic Molecules 
 
 The complete loss of fungicidal activity from the BSA and HSA samples that had 
been stripped of their lipophilic molecules is consistent with the hypothesis that the 
fungicidal factor is lipophilic in nature.  In order to further classify these lipophilic 
molecules, an acetone separation was performed as outlined in section 2.4 of the 
Materials and Methods.  In this separation, all polar lipids precipitate from the acetone 
solution while neutral and non-polar lipids remain soluble.  Sample volumes of 60µl of 
extract were utilized for the experiment.  This value was used since it represents the 
fungicidal dose associated with non-stripped BSA extractions.  A positive and negative 
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control was run alongside the separated sample.  To ensure that the dried acetone did not 
exhibit any fungicidal effects, sample volumes of acetone were dried and their reaction 
tubes were utilized in a cell viability assay.  In these control experiments, no change in 
cell viability was observed (data not shown). 
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Figure 11:  Lipid Separation was performed on the BSA extracts and a subsequent cell viability assay was 
performed.  A non-fractionated BSA extract sample was also run to determine the maximum amount of 
activity that should be recovered from the two fractions.  N=5.  Error bars represent Standard Error of the 
Mean (SEM). 
 
 
 As seen in Figure 11, 100% recovery of the fungicidal activity was contained in 
the acetone soluble (non-polar lipid) fraction of the separation.  The complete retention of 
activity in a single fraction may imply that there is a single factor responsible for the 
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fungicidal activity or if complementary factors are responsible, then they are very closely 
related in composition. 
 The same acetone separation procedure was performed on HSA extracts.  For the 
cell viability assay the same controls were utilized as stated previously for the BSA lipid 
separation cell viability assay. 
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Figure 12:  Lipid Separation was performed on the HSA extracts and a subsequent cell viability assay was 
performed.  A non-fractionated HSA extract sample was also run to determine the maximum amount of 
activity that should be recovered from the two fractions.  N=5.  Error bars represent Standard Error of the 
Mean (SEM). 
 
 The results obtained from the HSA lipid fractionation experiment mimicked those 
of the BSA lipid separation experiment.  However, only 60 µl of the extract was utilized 
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per sample and there was only a 24% loss of cell viability in the HSA fungicidal activity 
control.  This loss in cell viability is consistent with the values obtained during the HSA 
extract dosing studies (refer to Figure 7).  It is important to note that all of the fungicidal 
activity was retained within the non-polar lipid fraction of the separation.  This result 
matches the results obtained from the BSA lipid separation experiments and further 
supports the hypothesis that the same molecule is responsible for the fungicidal activity 
in both extracts. 
In order to eliminate the possibility that the process of the acetone separation was 
conferring the fungicidal effect exhibited by the samples.  Acetone separations and fungal 
cell viability assays were performed on fatty acid free albumin samples of human and 
bovine origin (Appendix B, Figures 13 and 14). 
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4 Future Directions 
4.1 Identification of the Fungicidal Factor 
 The further purification and identification of the fungicidal agent should be the 
first task undertaken in the progression of this project.  This would provide both the 
identity of the molecule responsible and would also elucidate whether or not it is the 
same factor responsible for the activity in both human and bovine species.  Since the cell 
viability assays were carried out using GPP media, the factor seems to be somewhat 
tolerable to hydrophilic conditions, and purification utilizing normal aqueous buffers 
should be feasible.  Solubility studies will need to be performed in order to determine the 
extent of the factor’s aqueous solubility.  Preliminary attempts to purify this molecule 
using size-exclusion, ion exchange, and hydrophobic chromatography on a Biorad 
Duoflow FPLC machine proved unsuccessful (data not shown).  It is possible that the 
factor was precipitating under these buffer conditions and was getting trapped in the pre-
purification filtration step or was subsequently being retained on the column via 
precipitation or non-ideal interactions. 
 Solvent-based separation on a HPLC chromatography system should prove useful 
in the further purification of this molecule.  In addition to this, mass-spectrometry would 
determine the approximate molecular weights of the components of the non-polar lipid 
fraction and might prove a useful starting point for HPLC purifications. 
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4.2 Interspecies Conservation   
 Since this factor is present in both bovine and human serum albumin samples, it 
would be interesting to see if this factor could also be obtained from various other 
mammalian species.  Some of the commercially available serum albumins from 
mammalian species include: canine, guinea pig, porcine, rabbit, rat, and sheep.  
Additionally, it would also prove beneficial to test albumins from non-mammalian 
sources, such as ovalbumin.  Preliminary testing of ovalbumin showed no fungicidal 
factor associated with it (data not shown), but more extensive testing should be 
performed to validate these results.  
 
4.3 Clinical Samples 
 Once the factor responsible for the fungicidal effect is identified, the analysis of 
clinical samples from healthy, Candida-colonized but non-symptomatic, and VVC 
afflicted women should be performed.  This analysis would reveal the physiologic levels 
of the fungicidal factor in relation to host-pathogen interactions.  It would be interesting 
to see if the levels of the factor increase in the cervico-vaginal fluid in women afflicted 
with VVC.  The cervico-vaginal fluid proteome mapped by Tang et al shows an increase 
in albumin concentrations of the fluid in response to Candida colonization (Tang).  Since 
the fungicidal factor associates with serum albumins and albumin concentrations in the 
cervical-vaginal fluid increase in response to Candida colonization, experiments 
investigating the reason for the increase in albumin transcytosis across the vaginal 
epithelium should be performed. 
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4.4 Mechanism of Fungicidal Activity 
 Revealing the mechanism by which this factor is able to cause Candida albicans 
cell death would prove pivotal in ascertaining if this factor is suitable to be used in 
antifungal regimens.  The modes of fungicidal action are cell lysis and induction of 
apoptosis.  Microscopy should be able to reveal which cidal event is occurring since each 
event has different phenotypic characteristics.  Molecular studies would also be required 
in order to ascertain the details of the mechanism or the pathways involved in the 
fungicidal event.  Further characterization of the fungicidal activity against various 
Candida and non-Candida species would provide insight into whether or not this agent is 
Candida albicans specific or if it is a broad spectrum antifungal. 
 One common way that lipids are able to affect cell viability is through membrane 
disruption.  Since cell membranes are composed of a lipid bilayer, extracellular lipids are 
able to insert themselves into the cell membrane and disrupt membrane stability, 
biophysics, and various membrane-bound processes (Odds 2003).  Since DMSO affects 
membrane solubility, the fungicidal studies presented here in this thesis should be 
repeated with a nominal percentage of DMSO (0.5-1.0%) or in the absence of DMSO 
altogether.   
 
4.5 Cytotoxic Effects against Host Cells 
 In order to evaluate whether or not it would be feasible to utilize this factor as a 
pharmacologic agent against Candida albicans, host cell toxicity studies must be 
performed.  Even though the factor is produced by the host, the concentrations of the 
factor needed to elicit an antifungal effect may prove cytotoxic to host cells. 
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5 Discussion 
The original hypothesis that there is a small molecule, or molecules, associated 
with serum albumin that affect Candida albicans is supported by the results obtained in 
this thesis project.  The fact that the fungicidal activity can be extracted from serum 
albumins obtained from both bovine and human sources may implicate that this type of 
fungicidal effect is conserved in mammalian species.  A rudimentary extraction and 
screen using ovalbumin was performed and showed no traces of fungicidal activity (data 
not shown). This result gives further support for the possibility that this activity resides 
only in mammalian species.  Before any definitive conclusions about the conservation of 
this activity are made, experiments utilizing serum albumin samples from other 
mammalian species need to be performed. 
An interesting observation is that the specific activity exhibited by the samples 
obtained from the two separate sources varied.  Two possible causes for this variation 
are: a slight divergence of the fungicidal molecule’s composition between species or a 
difference in the albumin orthologs that either alters the number of binding sites per 
albumin molecule or the protein’s affinity to bind the fungicidal molecule.  Since the 
albumin samples were purchased, any molecule that is found in the samples that is not 
albumin is essentially considered a contaminant.  This raises an important question 
concerning the consistency of the lipid content associated with the albumin as the source 
and the batch of the albumin is changed.  In order to address this possibility, the data 
obtained from assays utilizing three separate batches of BSA that were purchased over 
the period of 14 months were compared.  The fungicidal activity seen in all three batches 
were identical to one another (data not shown).  These ideas concerning the cause of the 
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variation in activity are only a few of the possible causes for the change in activity.  The 
future identification and characterization of this factor should help elucidate the cause of 
the variation in fungicidal activity. 
 One possible identity of this molecule is indole-acetic acid (IAA).  IAA is 
naturally produced in the tissue and organs of mammals as a natural byproduct from the 
catabolism of the amino acid tryptophan and can also be obtained from a diet rich in 
vegetable stems (De Melo, 2004). IAA has also been demonstrated to be fungistatic (Prusty) as 
well as cytotoxic to eukaryotic cells at concentrations of 1mM (De Melo, 1997).  The 
fungistatic event is caused by a cell cycle arrest and is transient in nature (Prusty).  In order 
to reduce the toxicity of IAA within the organism, it is usually conjugated to an amino 
acid and transported via serum albumins (Tomasic). 
 From research performed in the Prusty laboratory, IAA is soluble in organic 
solvents (Prusty).  Whether or not IAA or its related conjugates are soluble in N-butanol 
would have to be addressed by performing solubility studies.  The properties of the 
conjugated amino acid or prosthetic group would greatly influence the overall solubility 
of the molecule.  Experiments utilizing commercially available IAA and IAA/amino acid 
conjugates can easily be performed to elucidate the extent of solubility of the molecules 
in both N-butanol as well as the assay medium.  Fungal viability assays could also be 
performed to either validate or eliminate the possibility that the factor might be IAA or 
one of its physiologic conjugates. 
 Analysis and comparison of fatty acid free samples gave the first insight into the 
characterization of the fungicidal molecule.  Since the serum albumin samples that were 
stripped of their lipophilic molecules exhibited no activity, we can deduce that this 
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molecule is a fatty acid or lipophilic in composition.  Since the primary role of serum 
albumins is to act as a transport protein for lipids and fatty acids (Kragh-Hansen 2000), it is not 
surprising that the fungicidal factor extracted from them is lipophilic in nature. Although 
extracts of fatty acid free albumin samples yield a substantial pellet, the absence of any 
fungicidal activity gives reassurance that the fungicidal activity seen in the unstripped 
samples is not the result of nonspecific interactions.   
The cell viability assays performed on the acetone-fractionated samples were 
utilized to further characterize the fungicidal activity.  Solvent fractionation is the 
simplest, and sometimes most efficient, way for separating a group of lipids of interest.  
The use of ice-cold acetone as the fractionating solvent allows a complete, one-step 
separation of polar lipids, such as phospholipids and glycolipids, from all neutral or non-
polar lipids such as triglycerides and cholesterol.  In this fractionation, all the polar lipids 
are present in the precipitate, while all neutral or no-polar lipids are contained in the 
acetone layer.  In fractionation assays all activity possessed in the original un-fractionated 
sample were recovered in the acetone layer of the fractionation, implying that the 
fungicidal molecule is a neutral or non-polar lipid.  
 Samples of acetone by itself were also processed and assayed in order to ensure 
that the fungicidal effect is not due to chemical byproducts that may be present in the 
solvent.  No adverse effect on cell viability was seen in this assay (Data not shown).  For 
a negative control, the extracts obtained from fatty acid free albumins were also acetone 
fractionated and assayed for the presence of any fungicidal effect.  As was expected, no 
decrease in cell viability was observed from these experiments. 
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The suggestion that this factor is a conjugate of IAA is only one possibility that 
was based off of literature reviews and needs more extensive experimental validation.  
The factor may very well be a simple or modified non-polar lipid.  Non-polar lipids that 
are typically found dissolved in this organic layer are:  glycerides, sterols, sterol esters, 
carotenoids, and lipid soluble vitamins. 
The fungicidal mechanism is completely unknown and further research will be 
needed in order to establish a working model system.  It is also unclear whether or not 
this fungicidal activity is directly attributed to the factor itself or if it is being induced 
through downstream processes affected by the binding of the lipid to a receptor.  It is 
possible that the factor itself is not fungicidal but after entry into the yeast cell enzymatic 
processes convert the factor into a fungicidal agent.  If enzymatic conversion of the factor 
is the source of the effect, and the process is Candida specific, the factor might prove to 
be highly selective and effective as a pharmacologic agent.   
Further analysis by mass spectrometry and extensive purification will be required 
to further purify and identify the responsible entity. Identification of this molecule and its 
fungicidal mechanism may be pivotal in the understanding of how the human immune 
system interacts with fungal species that are both commensal and pathogenic organisms 
of the vaginal tract. 
 
6 Conclusions 
 The significant reduction of SC5314 cell viability upon incubated with N-butanol 
extracts from bovine and human albumins, provides a solid basis for the presence of a 
fungicidal molecule associated with serum albumins.  Furthermore, the absence of this 
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fungicidal activity in fatty acid free albumin samples provides preliminary evidence that 
this factor is lipophilic in composition.  Fungal viability assays upon the acetone 
separation fractions further characterize this lipophilic molecule as a neutral lipid.  
Although fungal cell viability assays show a difference in activity between human and 
bovine extracts, the fact that upon lipid separation, both extracts retained all of their 
fungicidal activity in the non-polar lipid fraction suggests that factor responsible for both 
extracts are of the same general classification.  Further research will need to be carried 
out in order to identify the molecule responsible as well as its fungicidal mechanism. 
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Appendix A: Abbreviations 
VVC Vulvovaginal Candidiasis 
RVVC Recurrent Vulvovaginal Candidiasis 
FDA Food and Drug Administration 
ADMET Absorption Distribution Metabolism Excretion Toxicology 
LD50 Lethal Dose 50% 
LD100 Lethal Dose 100% 
AIDS Acquired ImmunoDeficiency Syndrome 
SAP Secreted Aspartyl Protease 
HRT Hormone Replacement Therapy 
CMI Cell-Mediated Immunity 
Th1 T helper cells 1 
Th2 T helper cells 2 
TGF-β Transforming Growth Factor Beta 
NKs Natural Killer Cells 
PMNs Polymorphonuclear Nuetrophils 
CVF Cervical-Vaginal Fluid 
BSA Bovine Serum Albumin 
HSA Human Serum Albumin 
FAF Fatty Acid Free 
YPD Yeast Peptone Dextrose 
dH2O Deionized Water 
OD Optical Density 
Rpm Rotations Per Minute 
ml Milliliter 
mg Milligram 
µl Microliter 
µg Microgram 
GPP Glucose Phosphate Proline Media 
mM Millimolar 
DMSO Dimethyl Sulfoxide 
CFU Colony Forming Units 
FPLC Fast Protein Liquid Chromatography 
HPLC High Performance Liquid Chromatography 
IAA Indoleacetic Acid 
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Appendix B:  Acetone Separation Controls 
In order to eliminate the possibility that the acetone separation is conferring a 
fungicidal property to the non-polar lipid fraction, that is not attributed to the separation 
of an albumin associated factor, the acetone separations and subsequent cell viability 
assays were performed on the extracts obtained from BSA and HSA samples that had 
been stripped of their lipophilic molecules (Figures 15 and 16).   
 As predicted, there was no fungicidal activity observed in either the BSA and 
HSA fungicidal controls or the fractions obtained from them through acetone separation.  
This indicates that the fungicidal activity recovered in Figures 13 and 14 represents a 
recovery of fungicidal activity caused from the purified albumin factor. 
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Figure 13:  Lipid Separation was performed on the FAF BSA extracts and a subsequent cell viability assay 
was performed.  A non-fractionated FAF BSA extract sample was also run to determine the maximum 
amount of activity that should be recovered from the two fractions.  As expected no fungicidal effect was 
seen in any of the samples.  N=5.  Error bars represent Standard Error of the Mean (SEM). 
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Figure 14:  Lipid Separation was performed on the FAF HSA extracts and a subsequent cell viability assay 
was performed.  A non-fractionated FAF HSA extract sample was also run to determine the maximum 
amount of activity that should be recovered from the two fractions.  As expected no fungicidal effect was 
seen in any of the samples.  N=5.  Error bars represent Standard Error of the Mean (SEM). 
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Appendix C:  Foundation for the Thesis Hypothesis 
 The original aim of my graduate research was to isolate and characterize a 
secreted factor of a cervical-vaginal commensal that prevents Candida albicans hyphal 
formation.  Identification of this factor would help explain how Candida albicans, a 
natural commensal of the cervical-vaginal tract as well as a pathogen, is prevented from 
establishing an infection of its host.  The commensal bacteria were investigated for 
secreted factors due to research conducted by J.D. Sobel that showed that vulvovaginal 
candidiasis is marked by an ablation of the normal bacterial flora (sobel 1988).  Whether or 
not the loss of the normal vaginal flora occurs before, after, or during the establishment 
of an infection is unknown.  If the loss of the healthy vaginal flora occurs before the onset 
of vulvovaginal candidiasis, then it is possible that the loss of the normal flora and its 
secreted products may give Candida albicans an infection opportunity.  Clinical studies 
also revealed that with the onset of Gardnarella vaginallis induced bacterial vaginitis, 
there is a significant reduction in the concentration of C. albicans in the vaginal flora 
(Sobel 1988).   
 A collection of clinical commensal isolates provided by ECI Biotech was cultured 
in aliquots of a Simulated Vaginal Growth Media (Geshnizgani and Onderdonk).  This collection of 
isolates was, for the most part, comprised of Lactobacillus spp., the predominate 
commensals of a healthy vaginal flora, and Gardnarella vaginallis strains.   The spent 
media provided from these cultures were than divided and processed for either protein 
purification or organic extractions.  Protein purification experiments were utilized to 
isolate any proteins or peptides that might affect the C. albicans filamentation response, 
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while organic extractions were used to extract any small molecules that might affect the 
filamentation response. 
 In preliminary experiments, it was revealed that the organic extraction control (an 
N-butanol extraction of the Simulated Vaginal Growth Media, SVGM) exhibited 
fungicidal activity when introduced into a Candida albicans viability assay (data not 
shown).  Upon testing the individual components of the SVGM, it was discovered that 
the fungicidal activity was only present in the albumin component of the media (results 
not shown).  Searches of the literature showed that there was no known antifungal 
naturally produced by mammals and associated with serum albumins.  Investigation and 
characterization of the molecule developed into the research presented in this thesis. 
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